Coherent Diagnostic Technology, a developer of optical coherence tomography (OCT) systems for medical imaging applications, is changing its name to LightLab Imaging. Paul Magnin, president and CEO of LightLab, said his company predicts that light will
Coherent Diagnostic Technology, a developer of optical coherence tomography (OCT) systems for medical imaging applications, is changing its name to LightLab Imaging. Paul Magnin, president and CEO of LightLab, said his company predicts that light will have an important role in imaging and medicine, and the new name better captures this movement.
Systems using OCT have already been deployed for use in ophthalmic applications (SCAN 9/1/99). The FDA is reviewing several LightLab Imaging products using OCT for market clearance. In addition, the company has products in the pipeline that it will submit to the FDA in the near future, according to a company spokesperson.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.